51.

Acuff,

52.

Thakrar

53.

Nosyk

54.

Axeen

55.

Caritis,

56.

Fontes

57.

Zemore

58.

Hendershot

59.

Suen

60.

Ezard

---

This

CME:

---

Original

Audio

Executive

A

---

This

The

---

Email:

Facebook:

Facebook

Instagram:

Threads:

YouTube:

Twitter/X:

---

Addiction

Learn more about your ad choices. Visit megaphone.fm/adchoices

PSAM Review (Page 6):

---

Some of Our Favorite Addiction Medicine Resources:

Email alerts 

Google Alerts 

Evidence Alerts 

Email newsletters 

Recovery Research Institute 

ASAM weekly (with an associated podcast!) 

Alcohol, Drugs, and Health: Current Evidence 

Podcasts 

The Curbsiders Addiction Medicine Podcast 

Addiction Medicine Made Easy

The Addiction Medicine Journal Club

Online learning modules 

Providers Clinical Support System (PCSS) 

ASAM eLearning 

Journals  

The Journal of Addiction Medicine 

JAMA Network Open, Substance Use and Addiction Medicine 

Substance Use and Addiction Journal 

Conferences 

Pennsylvania Society of Addiction Medicine 

American Society of Addiction Medicine 

American Academy of Addiction Psychiatry  

This podcast episode does not offer CME, but other episodes do.

CME:

---

Original theme music: composed and performed by Benjamin Kennedy

Audio editing: Michael Bonanno

Executive producer: Dr. Patrick Beeman

A podcast from Ars Longa Media

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.

The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.

---

---

Addiction

Learn more about your ad choices. Visit megaphone.fm/adchoices

In episode 63 we discuss the association between buprenorphine dose and neonatal opioid withdrawal syndrome.

Marc B, Marion D, François B, Lakshmipriya L. Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity? Am J Addict. 2025 Jan;34(1):15-20.

We also discuss private equity in health care and nitrous oxide (Galaxy Gas).

AMA Journal of Ethics: Is Pursuing Profit Commensurable With Providing Good Health Care?

David T. Zhu: presentation on private equity at the 2025 From Research to Recovery Conference.

Smithsonian Magazine: The Long, Strange History of Nitrous Oxide, a Popular Drug Users Have Been Inhaling for Hundreds of Years

---

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.

CME:

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.

The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.

Addiction Medicine Journal Club is intended for educational purposes

Learn more about your ad choices. Visit megaphone.fm/adchoices

In episode 62 we discuss the

Magane KM, et al.Oral

We also discuss reduced

NPR:Drug

Federal Register:Modifications

---

This podcast offers category 1

CME:

---

Original theme music:composed

Audio editing: Michael

Executive producer:Dr.

A podcast fromArs

---

This is

Learn more about your ad choices. Visit megaphone.fm/adchoices

In episode 61 we discuss pregnancy outcomes with bup/nlx compared to bup alone.

Straub L, et al. Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone. JAMA. 2024 Sep 10;332(10):805-816. doi: 10.1001/jama.2024.11501.

We also discuss the elimination of SAMHSA and methamphetamine-related deaths.

STAT News: Trump’s mental health and addiction problem

New York Times: As Fentanyl Deaths Slow, Meth Comes for Maine

---

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.

CME:

---

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.

The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In episode 60 we discuss treating methamphetamine use disorder with lisdexamfetamine (Vyvanse).

Ezard N, et al; The LiMA Investigator Group. Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial. Addiction. 2024 Dec 19.

We also discuss why some people don’t get hangovers, and tianeptine, otherwise known as gas station heroin.

New York Times:The People Who Never Get Hangovers

Pain Therapeutics:Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse

---

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make

CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/

---

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In episode 59 we discuss outpatient low-dose initiation of buprenorphine.

Suen LW, et al. Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl. JAMA Netw Open. 2025 Jan 2;8(1):e2456253.

We also discuss impulse control dysregulation from ropinerole, and the new non-opioid painkiller, suzetrigine.

BBC:Prescription medication made me a gambling addict

Grall-Bronnec M, et al.Dopamine agonists and impulse control disorders: a complex association. DrugSaf. 2018;41(1):19-75.

FDA:FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

Vertex Pharmaceuticals: Randomized, Placebo-Controlled, Phase 3 Trials of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor for Treatment of Acute Pain After

---

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.

CME:https://micaresed.org/courses/podcast-addiction-medicine-journal-club/

---

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.  

The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. 

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In episode 58 we discuss a randomized controlled trial of semaglutide for alcohol use disorder. 

Hendershot CS, Bremmer MP, Paladino MB, Kostantinis G, Gilmore TA, Sullivan NR, Tow AC, Dermody SS, Prince MA, Jordan R, McKee SA, Fletcher PJ, Claus ED, Klein KR. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2025 Feb 12:e244789.  

We also discuss benzodiazepine tapering guidelines and new ways to use Sublocade. 

ASAM Clinical Practice Guideline on Benzodiazepine Tapering 

Sublocade label changes 

--- 

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. 

CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ 

--- 

---  

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.  

The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. 

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode we discuss 4 more articles that changed our practice. Listen to us talk through real cases, what we used to do, and what we do now.   

Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial. JAMA. 2024 May 28; 331(20):1722-1731. 

Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024 Jun 3;7(6):e2417377. 

Understanding the shared meaning of recovery from substance use disorders: New findings from the What is Recovery? Study. Substance Abuse: Research and Treatment, 17, 1–12.  

Long-term buprenorphine treatment for kratom use disorder: A case series. Substance Abuse, 2022. 43(1), 763–766. 

---

ASAM Advocacy Center

—

Thank you to the Pennsylvania Society of Addiction Medicine!

--- 

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. 

CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ 

--- 

--- 

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.  

The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. 

Email: [email protected]  

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode we discuss 4 articles that changed our practice. Listen to us talk through real cases, what we used to do, and what we do now.

Quantifying a potential protective effect of buprenorphine on fatality risk during acute fentanyl exposures. Journal of Substance Use and Addiction Treatment, Volume 158, 2024. 209252, ISSN 2949-8759.

Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge. JAMA Netw Open. 2024 Mar 4;7(3):e243387.

Association of Cannabis Use With Cardiovascular Outcomes Among US Adults. J Am Heart Assoc. 2024 Mar 5;13(5):e030178.

Association of random and observed urine drug screening with long-term retention in opioid treatment programs. Drug Alcohol Depend. 2024 Feb 1;255:111067.

---

ASAM Advocacy Center

---

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.

CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/

---

Original theme music: composed and performed by Benjamin Kennedy

Audio editing: Michael Bonanno

Executive producer: Dr. Patrick Beeman

A podcast from Ars Longa Media

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.

The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

Learn more about your ad choices. Visit megaphone.fm/adchoices